Adenosinergic Receptor Antagonists: Clinical Experience in Parkinson’s Disease
2015
In the management of Parkinson’s disease, chronic L-DOPA therapy is associated with the development of motor fluctuations and dyskinesias. Since L-DOPA is the most effective antiparkinsonian medication currently available, adjunctive medications that reduce or prevent fluctuations and dyskinesias could be of great value.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
0
Citations
NaN
KQI